AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Enginzyme AB raises SEK 75 million in a new equity round to advance its commercial biomanufacturing strategy.
PRIVATESep 23, 2026•about 4 hours ago
Amount Raised
SEK75 Million
Round Type
Venture - Series Unknown
SwedenBiotechnology
Description
Enginzyme AB has closed a new equity round raising SEK 75 million. The round marks a key milestone in the company's shift from R&D to a commercially driven strategy. Aymeric de Gantes, the CEO, stated that closing the new investment round was a priority. New shareholders with complementary expertise will contribute to their mission to deliver biomanufacturing solutions.
Company Information
Company
EnginZyme
Location
Sweden
About
Founded in Sweden in 2014, EnginZyme wants to play a key role in tackling climate change by enabling green chemistry for every industry. By replacing traditional fossil-based manufacturing with the patented cell-free technology platform, EnginZyme seeks to accelerate the shift toward the sustainable biomanufacturing of products that modern society relies on.
EnginZyme is recognised as a Technology Pioneer by the World Economic Forum, named a Global Cleantech 100 company, and is backed by an international syndicate of investors: Sofinnova Partners, Industrifonden, SEB GreenTech VC, Almi Invest GreenTech, Navigare Ventures and Bunge Ventures. To learn more, go to www.enginzyme.com.
Fundz sees it the moment EnginZyme raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SwedenBiotechnology